Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Efflux MexAB-Mediated Resistance in Multidrug and Pan-Drug Resistant Strains of Pseudomonas aeruginosa Isolated From Patients With Burn and Wound Infections

Azar Dokht Khosravi 1 , 2 and Ali Mohammadian 3 , *
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Arvand International Division, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2016, 11 (1); e25352
  • Published Online: January 1, 2016
  • Article Type: Research Article
  • Received: November 15, 2014
  • Revised: January 6, 2015
  • Accepted: May 9, 2015
  • DOI: 10.17795/jjnpp-25352

To Cite: Khosravi A D, Mohammadian A. Efflux MexAB-Mediated Resistance in Multidrug and Pan-Drug Resistant Strains of Pseudomonas aeruginosa Isolated From Patients With Burn and Wound Infections, Jundishapur J Nat Pharm Prod. 2016 ; 11(1):e25352. doi: 10.17795/jjnpp-25352.

Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures JP, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect. 2004; 57(3): 209-16[DOI][PubMed]
  • 2. Jung R, Fish DN, Obritsch MD, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004; 57(2): 105-11[DOI][PubMed]
  • 3. Tsutsui A, Suzuki S, Yamane K, Matsui M, Konda T, Marui E, et al. Genotypes and infection sites in an outbreak of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2011; 78(4): 317-22[DOI][PubMed]
  • 4. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis. 2005; 5: 24[DOI][PubMed]
  • 5. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006; 55: 1619-29[DOI][PubMed]
  • 6. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update. Drugs. 2009; 69(12): 1555-623[DOI][PubMed]
  • 7. Zechini B, Versace I. Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov. 2009; 4(1): 37-50[PubMed]
  • 8. Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plesiat P. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother. 2004; 48(5): 1797-802[PubMed]
  • 9. Yoneyama H, Maseda H, Kamiguchi H, Nakae T. Function of the membrane fusion protein, MexA, of the MexA, B-OprM efflux pump in Pseudomonas aeruginosa without an anchoring membrane. J Biol Chem. 2000; 275(7): 4628-34[PubMed]
  • 10. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003; 2(1): 48-62[PubMed]
  • 11. Forbes BA, Sahm DF, Weissfeld AS. Diagnostic microbiology. 2005;
  • 12. Clinical and Laboratory Standards Institute. . Performance Standards for Antimicrobial Susceptibility Testing; 21th Informational Supplement. Wayne;. 2012;
  • 13. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother. 2005; 56(1): 122-7[DOI][PubMed]
  • 14. Xavier DE, Picao RC, Girardello R, Fehlberg LC, Gales AC. Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol. 2010; 10: 217[DOI][PubMed]
  • 15. Thong KL, Lai KS, Ganeswrie R, Puthucheary SD. Pulsed-field gel electrophoresis of multidrug-resistant and -sensitive strains of Pseudomonas aeruginosa from a Malaysian hospital. Jpn J Infect Dis. 2004; 57(5): 206-9[PubMed]
  • 16. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med. 2007; 39(3): 162-76[DOI][PubMed]
  • 17. Pellegrino FL, Teixeira LM, Carvalho Md Mda G, Aranha Nouer S, Pinto De Oliveira M, Mello Sampaio JL, et al. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol. 2002; 40(7): 2420-4[PubMed]
  • 18. Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, Byl B, et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol. 2005; 43(3): 1198-204[DOI][PubMed]
  • 19. Rastegar Lari AR, Alaghehbandan R, Akhlaghi L. Burn wound infections and antimicrobial resistance in tehran, iran: an increasing problem. Ann Burns Fire Disasters. 2005; 18(2): 68-73[PubMed]
  • 20. Bayani M, Siadati S, Rajabnia R, Taher AA. Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran. Int J Mol Cell Med. 2013; 2(4): 204-9[PubMed]
  • 21. Khosravi AD, Mihani F. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagn Microbiol Infect Dis. 2008; 60(1): 125-8[DOI][PubMed]
  • 22. Nikaido H, Pages JM. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 2012; 36(2): 340-63[DOI][PubMed]
  • 23. Fuste E, Lopez-Jimenez L, Segura C, Gainza E, Vinuesa T, Vinas M. Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa. J Med Microbiol. 2013; 62: 1317-25[DOI][PubMed]
  • 24. Yi MY, Wang PY, Huang HJ, Liu YC. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa]. Zhonghua Yi Xue Za Zhi. 2006; 86(7): 457-62[PubMed]
  • 25. Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012; 40(2): 168-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments